These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5936016)

  • 21. Survival without tumor shrinkage: re-evaluation of survival gain by cytostatic effect of chemotherapy.
    Takahashi Y; Nishioka K
    J Natl Cancer Inst; 1995 Aug; 87(16):1262-3. PubMed ID: 7563175
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.
    Boehm T; Folkman J; Browder T; O'Reilly MS
    Nature; 1997 Nov; 390(6658):404-7. PubMed ID: 9389480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological activity of bacterial lectins and their molecular complexes with heterocyclic bis-adducts.
    Welchinskaya HV; Piecuszak B; Kovalenko EA; Sharykina NI; Getman KI; Podgorsky VS
    Mikrobiol Z; 2003; 65(5):20-5. PubMed ID: 14723158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
    Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
    Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antineoplastic effect of 1,4-benzoquinone guanylhydrazone thiosemicarbazone in experimental tumor models].
    Fichtner I; Arnold W
    Pharmazie; 1983 Feb; 38(2):130-1. PubMed ID: 6856663
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of neoplastic port site implants in laparoscopy: an experimental study.
    Schiavon CA; Pollara WM; Bevilacqua RG; Younes RN; Vieira da Motta TB; Cohen RV; Itinoshe M; Takasaka LH; Birolini D
    Surg Laparosc Endosc Percutan Tech; 1999 Aug; 9(4):274-8. PubMed ID: 10871176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug.
    Koga S; Hamazoe R; Maeta M; Shimizu N; Kanayama H; Osaki Y
    Cancer Res; 1984 May; 44(5):1840-2. PubMed ID: 6424932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of benzo(a)pyrene-induced carcinogenesis by vitamin C alone and by vitamin C/vitamin E and selenium/glutathione.
    Charalabopoulos K; Karkabounas S; Charalabopoulos AK; Papalimneou V; Ioachim E; Giannakopoulos X
    Biol Trace Elem Res; 2003; 93(1-3):201-12. PubMed ID: 12835502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Introduction of new screening system in National Cancer Institute].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
    [No Abstract]   [Full Text] [Related]  

  • 30. Liposomes as drug carriers in cancer therapy: hyperthermia and pH sensitivity as modalities for targeting.
    Yatvin MB; Cree TC; Tegmo-Larsson IM; Gipp JJ
    Strahlentherapie; 1984 Dec; 160(12):732-40. PubMed ID: 6393456
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental basis of adjuvant chemotherapy.
    Sakurai Y
    Prog Clin Biol Res; 1983; 132E():3-10. PubMed ID: 6647472
    [No Abstract]   [Full Text] [Related]  

  • 32. [Potentiation of focal ultrasound treatment of prostate adenocarcinoma by concomitant chemotherapy with estramustine phosphate and paclitaxel].
    Paparel P; Chapelon JY; Curiel L; Rabilloud M; Chesnais S; Gelet A
    Prog Urol; 2004 Feb; 14(1):40-6. PubMed ID: 15098750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasonic treatment of experimental animal tumours.
    Kremkau FW
    Br J Cancer Suppl; 1982 Mar; 5():226-32. PubMed ID: 6279136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EPR oximetry of tumors in vivo in cancer therapy.
    Sentjurc M; Cemazar M; Sersa G
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1379-85. PubMed ID: 15134738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A MITOMYCIN C-RESISTANT JENSEN RAT SARCOMA: CHEMOTHERAPY STUDIES.
    SUGIURA K; MERKER PC
    Cancer Res; 1963 Sep; 23():SUPPL 1475-82. PubMed ID: 14070402
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening data from the Cancer Chemotherapy National Service Centescreening laboratories. 34. Plant extracts.
    Abbott BJ; Leiter J; Hartwell JL; Caldwell ME; Beal JL; Perdue RE; Schepartz SA
    Cancer Res; 1966 Jul; 26(7 Pt 2):761-935. PubMed ID: 5944776
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug delivery to tumours: recent strategies.
    Reddy LH
    J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy for the 9L rat brain tumor model system.
    Vats TS; Kimler BF; Henderson SD; Morantz RA
    Cancer Treat Rep; 1982 Mar; 66(3):575-9. PubMed ID: 6174232
    [No Abstract]   [Full Text] [Related]  

  • 39. [New models of experimental chemotherapy of tumors].
    Treshchalina EM; Andronova NV; Kobliakov VA; Raĭkhlin NT
    Vopr Onkol; 2001; 47(6):701-5. PubMed ID: 11826492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some methods of raising the selectivity of action of antineoplastic drugs].
    Sof'ina ZP; Lagova ND; Lesnaia NA; Babushkina NA
    Vestn Akad Med Nauk SSSR; 1984; (5):70-7. PubMed ID: 6741252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.